Global Prosthetic Heart Valve Market Size Study & Forecast, by Valve (Transcatheter Heart Valves, Bioprosthetic (Tissue) Valves, Mechanical Valves), Material (Biological Tissue, Pyrolytic Carbon), End-use and Regional Forecasts 2025-2035

The Global Prosthetic Heart Valve Market is valued at approximately USD 9.64 billion in 2024 and is anticipated to grow with a strong CAGR of 8.70% over the forecast period of 2025–2035. Prosthetic or artificial heart valves, designed to replace malfunctioning native heart valves, have become pivotal in the management of valvular heart disease, one of the leading cardiovascular disorders worldwide. These life-saving devices are engineered either from biological tissue or mechanical materials and are deployed through surgical or transcatheter procedures. The market is witnessing a remarkable upswing as the burden of cardiovascular diseases accelerates globally, fueled by rising life expectancy, sedentary lifestyles, and a growing prevalence of risk factors such as hypertension, obesity, and diabetes. Moreover, continuous advancements in minimally invasive valve replacement techniques and the surge in adoption of transcatheter heart valve procedures have reshaped the therapeutic landscape, making them accessible to high-risk and elderly patient populations.

The expansion of the prosthetic heart valve market is further reinforced by the dramatic improvements in device durability, biocompatibility, and clinical outcomes. Transcatheter Aortic Valve Replacement (TAVR) has transformed into a mainstream therapeutic option and is witnessing exponential adoption due to its lower recovery times and reduced surgical risks compared to traditional open-heart surgery. According to the World Health Organization, cardiovascular diseases account for approximately 17.9 million deaths each year, with valvular heart disease representing a significant portion of these cases. The increasing number of clinical trials, government-backed health initiatives, and a swelling wave of investments in structural heart disease therapies are creating lucrative opportunities for market growth. Nonetheless, challenges such as the high cost of valve implants, the need for anticoagulation therapy in mechanical valves, and the disparity in access to advanced healthcare technologies in emerging economies could hinder the pace of adoption.

Regionally, North America held the lion’s share of the global prosthetic heart valve market in 2024, attributed to its robust healthcare infrastructure, strong penetration of advanced cardiovascular therapies, and supportive reimbursement frameworks. The United States, in particular, continues to lead in transcatheter valve adoption owing to favorable FDA approvals and broad physician acceptance. Europe follows closely, supported by high awareness levels, government initiatives, and increasing geriatric populations across countries like Germany, France, and the UK. Asia Pacific, however, is anticipated to witness the fastest growth throughout the forecast horizon. Rising healthcare expenditure, rapid urbanization, and surging cardiovascular disease burden in nations such as China and India are key accelerators. Moreover, collaborations between global medtech giants and regional healthcare providers are paving the way for expanded access to next-generation valve therapies. Meanwhile, Latin America and the Middle East & Africa, although growing at a comparatively moderate rate, are showing steady adoption patterns driven by improving healthcare infrastructure and gradual regulatory alignment with global standards.

Major market players included in this report are:
• Medtronic plc
• Abbott Laboratories
• Edwards Lifesciences Corporation
• Boston Scientific Corporation
• CryoLife, Inc.
• LivaNova PLC
• JenaValve Technology, Inc.
• Colibri Heart Valve LLC
• Meril Life Sciences Pvt. Ltd.
• Micro Interventional Devices, Inc.
• TTK Healthcare Limited
• Lepu Medical Technology Co., Ltd.
• Artivion, Inc.
• Corcym S.r.l.
• Braile Biomédica

Global Prosthetic Heart Valve Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Valve:
• Transcatheter Heart Valves
• Bioprosthetic (Tissue) Valves
• Mechanical Valves

By Material:
• Biological Tissue
• Pyrolytic Carbon

By End-use:
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more